Below are the most recent publications written about "Device Approval" by people in Profiles.
-
Williams MM, Smith NR, Uyl-de Groot CA, den Uil CA, Ross JS, Mohamed MO, Mamas MA, Banerjee A, Ko DT, Landon B, Cram P. Variations in the Medical Device Authorization and Reimbursement Landscape: A Case Study of 2 Cardiovascular Devices Across 4 Countries. Circ Cardiovasc Qual Outcomes. 2025 Apr; 18(4):e011636.
-
Samdani AF, Pahys JM, Ames RJ, Grewal H, Pelletier GJ, Hwang SW, Betz RR. Prospective Follow-up Report on Anterior Vertebral Body Tethering for Idiopathic Scoliosis: Interim Results from an FDA IDE Study. J Bone Joint Surg Am. 2021 09 01; 103(17):1611-1619.
-
Goh GS, Tornetta P, Parvizi J. Facilitating the Approval Process of Anti-Infective Technologies and Advancing Them to the Market: Insights from an FDA Workshop on Orthopaedic Device-Related Infections. J Bone Joint Surg Am. 2021 08 04; 103(15):e57.
-
Joynt Maddox KE, Bleser WK, Das SR, Desai NR, Ng-Osorio J, O'Brien E, Psotka MA, Wadhera RK, Weintraub WS, Konig M. Value in Healthcare Initiative: Summary and Key Recommendations. Circ Cardiovasc Qual Outcomes. 2020 07; 13(7):e006612.
-
Samsky M, Krucoff M, Althouse AD, Abraham WT, Adamson P, Aguel F, Bilazarian S, Dangas GD, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Laschinger J, Masters RG, Michelson E, Morrow DA, Morrow V, Ohman EM, Pina I, Proudfoot AG, Rogers J, Sapirstein J, Senatore F, Stockbridge N, Thiele H, Truesdell AG, Waksman R, Rao S. Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. Am Heart J. 2020 01; 219:1-8.
-
Khalid N, Rogers T, Shlofmitz E, Chen Y, Dan K, Torguson R, Weintraub WS, Waksman R. Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension. Cardiovasc Revasc Med. 2019 Oct; 20(10):891-896.
-
Nandra K, Ing R. Safety of orogastric tubes in foregut and bariatric surgery. Surg Endosc. 2018 10; 32(10):4068-4070.
-
Simons JP, Shue B, Flahive JM, Aiello FA, Steppacher RC, Eaton EA, Messina LM, Schanzer A. Trends in use of the only Food and Drug Administration-approved commercially available fenestrated endovascular aneurysm repair device in the United States. J Vasc Surg. 2017 05; 65(5):1260-1269.
-
Goudra BG, Singh PM. SEDASYS, sedation, and the unknown. J Clin Anesth. 2014 Jun; 26(4):334-6.
-
Chalouhi N, Jabbour P, Tjoumakaris S, Rosenwasser RH, Gonzalez LF. The pipeline embolization device: beyond the approved indication. World Neurosurg. 2014 May-Jun; 81(5-6):657-60.